Oracle Corp. buy Traumtanz
Start price
20.10.22
/
80%
€70.15
Target price
20.10.23
€72.00
Performance (%)
4.98%
End price
25.10.22
€73.64
Summary
This prediction ended on 25.10.22 with a price of €73.64. The BUY prediction by Traumtanz finished with a performance of 4.98%. Traumtanz has 80% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Oracle Corp. | 2.831% | 2.831% | 13.899% |
iShares Core DAX® | 1.560% | 4.721% | 18.671% |
iShares Nasdaq 100 | 0.517% | 1.171% | 23.619% |
iShares Nikkei 225® | 1.730% | 6.073% | 16.253% |
iShares S&P 500 | 1.482% | 1.218% | 23.290% |
According to Traumtanz what are the pros and cons of Oracle Corp. for the foreseeable future?
Pros
Future proof or reliable business model
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
High dividend yield expected
positive Cash Flow expected
Good rating
Standard Investments for future growth
Valuable balance sheet
ROE higher than 10% per year
Normal challenges to pay loans and raise capital
Capable Management
Good culture
Innovative
Some uniques
Differentiated customer and product portfolio
Growths faster than the competition
Sustainability is important
Stable Large shareholder and/or long term investor
Medium risks for its business
Top 10 in its market
Small cyclical dependencies
Well known brand
Cons
Comments by Traumtanz for this prediction
In the thread Oracle Corp. diskutieren
Buy mit Kursziel 72,0
In the thread Trading Oracle Corp.
Buy beendet
Stopped prediction by Traumtanz for Oracle Corp.
Oracle Corp.
Start price
Target price
Perf. (%)
€77.60
30.10.22
30.10.22
€80.00
30.10.23
30.10.23
2.81%
04.01.23
04.01.23
Future proof or reliable business model
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Oracle Corp.
Start price
Target price
Perf. (%)
€73.64
25.10.22
25.10.22
€80.00
25.10.23
25.10.23
5.38%
30.10.22
30.10.22
Future proof or reliable business model
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Oracle Corp.
Start price
Target price
Perf. (%)
€61.98
01.10.22
01.10.22
€65.00
01.10.23
01.10.23
6.66%
13.10.22
13.10.22
Future proof or reliable business model
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Oracle Corp.
Start price
Target price
Perf. (%)
€55.88
19.03.21
19.03.21
€61.00
2.06%
23.03.21
23.03.21
Future proof or reliable business model
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Oracle Corp.
Start price
Target price
Perf. (%)
€50.50
15.09.20
15.09.20
€55.00
04.11.21
04.11.21
2.30%
17.12.20
17.12.20
Future proof or reliable business model
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Oracle Corp.
Start price
Target price
Perf. (%)
€49.97
18.04.20
18.04.20
€55.00
04.05.20
04.05.20
-5.16%
04.05.20
04.05.20
Future proof or reliable business model
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Oracle Corp.
Start price
Target price
Perf. (%)
€41.83
20.03.20
20.03.20
€50.00
23.03.20
23.03.20
-0.98%
23.03.20
23.03.20
Future proof or reliable business model
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Oracle Corp.
Start price
Target price
Perf. (%)
€44.40
19.03.20
19.03.20
€55.00
19.03.20
19.03.20
-4.83%
19.03.20
19.03.20
Future proof or reliable business model
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Oracle Corp.
Start price
Target price
Perf. (%)
€37.64
13.03.20
13.03.20
€50.00
18.03.20
18.03.20
10.53%
18.03.20
18.03.20
Future proof or reliable business model
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected